Optalert2019-11-20T13:59:24+11:00

Mining / Road Transport

Optalert’s early warning drowsiness detection technology, protecting industry for over 20 years.  Improved safety, with maximum productivity.

Licensing

Optalert’s automotive video camera system. The smart blink system for detecting and monitoring drowsiness/alertness performance.

Pharmaceutical

BlinQ system, the next generation in measuring drowsiness/wakefulness in clinical drug trials.  Determine efficacy, safety and the right dose.

Neurology Research

Optalert gives researchers the potential to identify, track and detect precursors or changes in neurological disorders for early intervention.

Renowned as experts in drowsiness/wakefulness detection, Optalert is now exploring new pathways in the automotive industry, pharmaceutical drug trials and neurological research. Sign up today to keep up to date with the latest news from Optalert.

Dr Murray John’s latest publication – Now available

The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective

Current Psychopharmacology 2019, Volume 8 , Issue 1

Click here for your free copy

OPTALERT’S EARLY-WARNING SYSTEM IS TRUSTED BY MAJOR GLOBAL BLUE CHIP COMPANIES

Subscribe to our mailing list to stay informed of our major announcements

Translate » Language